Brief Summary
The speech addresses snake bites and venom poisoning as a neglected health crisis in Kenya, affecting thousands annually and causing deaths and disabilities. Kenya is actively working to combat this issue through integration into national health plans, enhanced surveillance, community education, and local antivenom research and production. The country aims to reduce snake bite-related deaths and disabilities by 2030, advocating for global action and accountability.
- Snake bites are a significant health issue in Kenya, leading to numerous deaths and disabilities.
- Kenya is actively addressing this crisis through various strategic initiatives and partnerships.
- The country is committed to local solutions, including antivenom production and improved healthcare access.
The Silent Crisis of Snake Bites in Kenya
Snake bite is described as a reflection of systemic inequities and neglect, affecting over 19,000 people annually in Kenya, resulting in approximately 800 deaths and numerous disabilities. These statistics represent real-life tragedies for affected families and communities. Kenya is committed to ending snake bite deaths and disabilities as a member of the Strikeout Snake Bite Initiative and chair of the Global Snake Bite Task Force.
Kenya's Strategic Response to Snake Bites
Since 2017, when snake bites were designated a neglected tropical disease by the WHO, Kenya has been focused on a response based on five strategic pillars: empowered communities, access to treatment, strong health systems, robust surveillance, and strategic partnerships. Snake bites were integrated into Kenya's national master plan for the elimination of NTDs in 2022, establishing a policy foundation for prevention, diagnosis, treatment, and care. Surveillance has been strengthened through digital platforms like the Kenya Health Information System, enabling real-time reporting and rapid response.
Advancements in Surveillance and Outreach
In 2023, community-based surveillance and education on snake bites were incorporated into mass drug administration campaigns, mapping high-risk areas and improving antivenom deployment and outreach. Kenya is focused on sustainable, homegrown solutions, including funding for local research and development of antivenom and building a foundation for domestic manufacturing anchored by standardized venom repositories and global technology transfer. This initiative aims to build health sovereignty beyond just addressing supply issues.
Training and Collaboration for Effective Care
Hundreds of clinicians and community health promoters have been trained to deliver timely and effective snake bite care. Multi-sectoral collaboration involves engaging policymakers, regulators, researchers, and civil society to prioritize snake bites on national and international health agendas. Challenges remain, including limited access to antivenom in remote areas, variable clinical capacity in hard-to-reach settings, and underreporting, especially among pastoralist and nomadic communities.
Global Advocacy and Future Commitments
At the 78th World Health Assembly, Kenya will leverage its leadership to advance coordinated global action, elevate visibility, strengthen advocacy, and mobilize partnerships and resources for global snake bite elimination targets. Kenya reaffirms commitments to integrate snake bite surveillance, prevention, and response across all NTD platforms and health outreach services, champion local innovation by accelerating domestic production of affordable antivenom, and enforce accountability by setting measurable national milestones to reduce snake bite-related deaths and disabilities by 2030. The goal is to ensure that snake bites no longer remain a hidden epidemic, emphasizing the need for urgency, unity, and resolve to reach every community, deliver timely care, and save lives.
